The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
THE GENETICS OF BREAST CANCER SUSCEPTIBILITY
Abstract
▪ Abstract Following the genomic localization and subsequent identification of the breast cancer susceptibility genes, BRCA1 and BRCA2, the basic patterns of cancer risk associated with mutations in these genes have been defined. In addition, preliminary insights into the prevalence of mutations and their contributions to cancer incidence have been acquired. Features of breast and other cancers that develop in these genetic syndromes have now been investigated and shown to differ from sporadic versions of the same neoplasms. However, several areas are complex and require further clarification. There remain discrepancies between published cancer risk estimates. Furthermore, there may be variation in cancer risk between different mutations in the same gene and there is preliminary evidence that genetic and nongenetic influences may modify risks. Finally, it is probable that the genes underlying a substantial component of susceptibility to breast cancer remain to be identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Self-citationGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Self-citationLinkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., & King, M.-C. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,550
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Self-citationRisks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Self-citationBreast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
BRCA1 Mutations in Primary Breast and Ovarian Carcinomas
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., et al. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,205
Genetic analysis of breast cancer in the cancer and steroid hormone study.
Claus, E. B., RISCH, N. J., & Thompson, W. D. (1991) · PubMed · Cited by 911
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 762
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 746
The genetic attributable risk of breast and ovarian cancer
Claus, E. B., Schildkraut, J. M., Thompson, W. D., & Risch, N. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960601)77:11<2318::aid-cncr21>3.0.co;2-z · Cited by 744
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Self-citationDoes this have a familiar RING?
Saurin, A. J., Borden, K. L. B., Boddy, M. N., & Freemont, P. S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80017-x · Cited by 635
Involvement of Brca2 in DNA Repair
Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., & Venkitaraman, A. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80035-0 · Cited by 634
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 585
Wong, A. K. C., Pero, R., Ormonde, P. A., Tavtigian, S. V., & Bartel, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.31941 · Cited by 539
Ford, D., Easton, D. F., & Peto, J. (1995) · Europe PMC (PubMed Central) · Cited by 528
From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair
Callebaut, I., & Mornon, J.-P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01312-9 · Cited by 524
Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
Self-citationHereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., & Lynch, H. T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w · Cited by 454
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
Verhoog, L., Brekelmans, C., Seynaeve, C., van den Bosch, L., Dahmen, G., van Geel, A., Tilanus-Linthorst, M., Bartels, C., Wagner, A., van den Ouweland, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07065-7 · Cited by 452
Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A. J., Stratton, M. R., & Easton, D. (1997) · Nature Genetics · doi:10.1038/ng0197-103 · Cited by 442
Self-citationTranscriptional activation by BRCA1
Chapman, M. S., & Verma, I. M. (1996) · Nature · doi:10.1038/382678a0 · Cited by 436
Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, V. L. J., & Ashworth, A. (1997) · Nature Genetics · doi:10.1038/ng1297-423 · Cited by 432
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
Petrij-Bosch, A., Peelen, T., van Vliet, M., Eijk, R. V., Olmer, R., Drüsedau, M., Hogervorst, F. B. L., Hageman, S., Arts, P. J. W., Ligtenberg, M. J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-341 · Cited by 432
Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1
Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351901 · Cited by 423
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/513891 · Cited by 387
Self-citationGerm-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340302 · Cited by 385
Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic, A., & Simpfendorfer, D. (1997) · PubMed · Cited by 370
Koonin, E. V., Altschul, S. F., & Bork, P. (1996) · Nature Genetics · doi:10.1038/ng0796-266 · Cited by 368
BRCA2 mutations in primary breast and ovarian cancers
Lancaster, J. M., Wooster, R., Mangion, J., Phelan, C. M., Cochran, C., Gumbs, C., Seal, S., Barfoot, R., Collins, N., Bignell, G., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-238 · Cited by 360
Self-citationAbeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., Zlotogora, J., Heching, N. I., & Peretz, T. (1997) · Europe PMC (PubMed Central) · Cited by 357
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
Neuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301885 · Cited by 335
Self-citationAberrant Subcellular Localization of BRCA1 in Breast Cancer
Chen, Y., Chen, C.-F., Riley, D. J., Allred, D. C., Chen, P.-L., Von Hoff, D., Osborne, C. K., & Lee, W.-H. (1995) · Science · doi:10.1126/science.270.5237.789 · Cited by 309
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
Neuhausen, S., Gilewski, T., Norton, L., Tran, T., McGuire, P., Swensen, J., Hampel, H., Borgen, P., Brown, K., Skolnick, M., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-126 · Cited by 304
Study of a single BRCA2 mutation with high carrier frequency in a small population.
Thorlacius, S., Sigurðsson, S., Bjarnadóttir, H., Ólafsdóttir, G. H., Jonasson, J. G., Tryggvadóttír, L., Tulinius, H., & Je, E. (1997) · Europe PMC (PubMed Central) · Cited by 294
An Association between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus
Krontiris, T. G., Devlin, B., Karp, D. D., Robert, N. J., & Risch, N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290801 · Cited by 287
BRCA1 Mutations in a Population-Based Sample of Young Women with Breast Cancer
Langston, A. A., Malone, K. E., Thompson, J. D., Daling, J. R., & Ostrander, E. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340301 · Cited by 286
Lynch, E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P. M., Kvinnsland, S., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/301639 · Cited by 276
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.
Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A. J., & Anton‐Culver, H. (1997) · PubMed · Cited by 275
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., & Henderson, B. E. (1997) · PubMed · Cited by 257
Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., & Stratton, M. R. (1992) · Nature Genetics · doi:10.1038/ng1092-132 · Cited by 250
Inherited p53 gene mutations in breast cancer.
Sidransky, D., Tokino, T., Helzlsouer, K. J., et al. (1992) · PubMed · Cited by 249
Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., Ormiston, W. J., Daly, P. A., Ford, D., & Easton, D. F. (1995) · PubMed · Cited by 243
Contribution of BRCA1 Mutations to Ovarian Cancer
Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., & Ponder, B. A. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361602 · Cited by 237
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Jóhannesdóttir, G., Guðmundsson, J., Bergþorsson, J. Þ., Arason, A., Agnarsson, B. A., Eiríksdóttir, G., Johannsson, O. T., Borg, Å., Ingvarsson, S., Easton, D. F., et al. (1996) · PubMed · Cited by 223
Differential Contributions of BRCA1 and BRCA2 to Early-Onset Breast Cancer
Krainer, M., Silva-Arrieta, S., FitzGerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362003 · Cited by 210
Phelan, C. M., Rebbeck, T. R., Weber, B. L., Devilee, P., Ruttledge, M. H., Lynch, H. T., Lenoir, G. M., Stratton, M. R., Easton, D. F., Ponder, B. A. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-309 · Cited by 201
Self-citationAndrés Conejero, R., Lastra del Prado, R., Zurera Berjaga, M., & Arévalo Vázquez, E. (2022) · Revisiones en Cáncer · doi:10.20960/revcancer.00003 · Cited by 193
p53 mutations in BRCA1-associated familial breast cancer
Crook, T., Crossland, S., Crompton, M. R., Osin, P., & Gusterson, B. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63327-2 · Cited by 179
A polymorphic stop codon in BRCA2
Mazoyer, S., Dunning, A. M., Serova, O., Dearden, J., Puget, N., Healey, C. S., Gayther, S. A., Mangion, J., Stratton, M. R., Lynch, H. T., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-253 · Cited by 174
Self-citationThe BRC repeats are conserved in mammalian BRCA2 proteins
Bignell, G. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.1.53 · Cited by 174
Germline BRCA1 185delAG mutations in Jewish women with breast cancer
Offit, K., McGuire, P., Schluger, A. E., Hampel, H., Brown, K., Gilewski, T. A., Norton, L., Swensen, J. J., Neuhausen, S. L., Skolnick, M. H., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91484-1 · Cited by 166
Risk modifiers in carriers of brca1 mutations
Narod, S. A., Goldgar, D., Cannon‐Albright, L., Weber, B., Moslehi, R., Ives, E., Lenoir, G., & Lynch, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640608 · Cited by 164
BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion?
Zhang, H., Tombline, G., & Weber, B. L. (1998) · Cell · doi:10.1016/s0092-8674(00)80936-8 · Cited by 156
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q
Stratton, M. R., Ford, D., Neuhasen, S., Seal, S., Wooster, R., Friedman, L. S., King, M., Egilsson, V., Devilee, P., McManus, R., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-103 · Cited by 156
Self-citationBRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
Grétarsdóttir, S., Thorlacius, S., Valgardsdottir, R., Gudlaugsdottir, S., Sigurðsson, S., Steinarsdóttir, M., Jonasson, J. G., Anamthawat‐Jónsson, K., & Eyfjörd, J. E. (1998) · PubMed · Cited by 153
Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.
Swensen, J., Hoffman, M. D., Skolnick, M., & Neuhausen, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1513 · Cited by 152
Inherited susceptibility to breast cancer.
Easton, D. F., Ford, D., & Peto, J. (1993) · PubMed · Cited by 140
Breast Cancer in Men: Aspects of Familial Aggregation
Rosenblatt, K. A., Thomas, D. B., McTiernan, A., Austin, M. A., Stalsberg, H., Stemhagen, A., Thompson, W. D., Curnen, M. G. M., Satariano, W. A., Austin, D. F., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.12.849 · Cited by 125
Porter, D., Cohen, B. B., Wallace, M. R., Smyth, E., Chetty, U., Dixon, J. M., Steel, C. M., & Carter, D. C. (1994) · British journal of surgery · doi:10.1002/bjs.1800811038 · Cited by 122
Foulkes, W. D., Wong, N., Brunet, J., Bégin, L. R., Zhang, J. C., Martinez, J. J., Rozen, F., Tonin, P. N., Narod, S. A., Karp, S. E., et al. (1997) · PubMed · Cited by 122
High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked families
Cornelis, R. S., Neuhausen, S. L., Johansson, O., Arason, A., Kelsell, D. P., Ponder, B. A. J., Tonin, P. N., Hamann, U., Lindblom, A., Lalle, P., et al. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870130310 · Cited by 119
Collins, N., Wooster, R., & Stratton, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.526 · Cited by 103
Self-citationA breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
Ramus, S. J., Friedman, L. S., Gayther, S. A., Ponder, B. A. J., Bobrow, L. G., van der Looji, M., Papp, J., & Oláh, E. (1997) · Nature Genetics · doi:10.1038/ng0197-14 · Cited by 82
Beller, U., Halle, D., Catane, R., Kaufman, B., Hornreich, G., & Levy‐Lahad, E. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4844 · Cited by 78
Sobol, H., Stoppa‐Lyonnet, D., Paillerets, B. B., Peyrat, J. P., Kerangueven, F., Janin, N., Noguchi, T., Eisinger, F., Guinebretière, J. M., Jacquemier, J. D., et al. (1996) · PubMed · Cited by 64
Cloning, Chromosomal Mapping and Expression Pattern of the Mouse Brca2 Gene
Connor, F., Smith, A. L., Wooster, R., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.291 · Cited by 59
Evidence for a third breast-cancer susceptibility gene
Sobol, H., Birnbaum, D., & Eisinger, F. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90655-6 · Cited by 35
Savelyeva, L., Claas, A., Gier, S., et al. (1998) · PubMed · Cited by 24
BRCA1 mutations and survival in women with ovarian cancer.
Brunet, J., Narod, S. A., Tonin, P. N., & Foulkes, W. D. (1997) · PubMed · Cited by 20
Cited by
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3181 · Cited by 1,469
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,006
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 956
Yoshida, K., & Miki, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02195.x · Cited by 753
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Metadata
- Authors
- Rahman, N., & Stratton, M. R.
- Venue
- Annual Review of Genetics
- Publisher
- Annual Reviews
- Published
- 1998-12
- Volume
- 32
- Issue
- 1
- Pages
- 95-121
- ISSN
- 0066-4197 (ISSN-L)
- 1545-2948
- OpenAlex
- W2122089700
- Cited by
- 295
- References
- 80
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.